Crossmark

Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

Crossref DOI link: https://doi.org/10.1186/s12885-020-06895-1

Published Online: 2020-05-11

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kuriyama, Naohisa https://orcid.org/0000-0002-9668-0500
Usui, Masanobu

Gyoten, Kazuaki

Hayasaki, Aoi

Fujii, Takehiro

Iizawa, Yusuke

Kato, Hiroyuki

Murata, Yasuhiro

Tanemura, Akihiro

Kishiwada, Masashi

Sakurai, Hiroyuki

Mizuno, Shugo

Isaji, Shuji
License Information

Text and Data Mining valid from 2020-05-11

Version of Record valid from 2020-05-11
More Information

Article History

Received: 10 March 2020

Accepted: 23 April 2020

First Online: 11 May 2020

Ethics approval and consent to participate

: They all gave their written informed consent for inclusion in the study. All patients were warned of the risks of treatment, especially concerning the possibility of developing distant metastases after NAC. The study protocol was approved by the medical ethics committee of Mie University Hospital (ID2954, UMIN ID: 000030980), and the study was performed in accordance with the ethical standards established in the 1964 Declaration of Helsinki.

: Not applicable.

: The authors have nothing to disclose on competing interests.

Document is current

Any future updates will be listed below